Harrison Rosemary 4
4 · TCR2 THERAPEUTICS INC. · Filed Jan 12, 2022
Insider Transaction Report
Form 4
Harrison Rosemary
Chief Business & Strategy
Transactions
- Award
Stock Option (Right to Buy)
2022-01-10+191,102→ 191,102 totalExercise: $4.04Exp: 2032-01-09→ Common Stock (191,102 underlying)
Footnotes (1)
- [F1]25% of this option shall vest and become exercisable on January 10, 2023, with the remainder vesting in thirty-six (36) equal monthly installments thereafter.